Skip to search formSkip to main contentSkip to account menu

monafram

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
The hemorheologic disorders, which are potentially deleterious in a wide range of pathologies, were studied in patients with type… 
2014
2014
The reversible aggregation of red blood cells (RBCs) continues to be of the basic science and clinical interest. Recently it has… 
2012
2012
There are complex interactions between blood cells, and erythrocytes may enhance platelet aggregation. However, there is a lack… 
2011
2011
Aim. To study of efficacy and safety of glycoprotein IIb/IIIa blocker monafram in acute ST-segment elevation myocardial… 
2010
2010
Glycoprotein (GP) llb-llla anagonist monafram is the F(ab)2 fragments of anti GP llb llla monoclonal antibody FraMon (CRC64… 
2005
2005
The ability of different ligands of glycoprotein (GP) IIb-IIIa (αIIb/β3-integrin) to support platelet aggregation stimulated by… 
2005
2005
New glycoprotein (GP) IIb-IIIa antagonist preparation framon (Monafram), is the F(ab')(2) fragment of a monoclonal antibody… 
2004
2004
First Russian glycoprotein (GP) IIb-IIIa antagonist, preparation Monafram, is the F(ab')2 fragment of anti-GP IIb-IIIa monoclonal…